Research Technician in Professor Gerhardt Attard's Treatment Resistance Research Group at the UCL Cancer Institute, dedicated to advancing prostate cancer treatment. Currently contributing to a clinical trial that aims to identify which patients benefit most from androgen deprivation therapy (ADT) alongside salvage radiotherapy post-prostatectomy.With a background in Biomedical Science and hands-on experience in the molecular and histopathology labs at University College London Hospital's Neuropathology Department, I completed my IBMS portfolio and gained valuable skills in diagnostics and analysis. Passionate about genomic science and cancer research, I’m driven by the vision to make impactful contributions to transformative biomedical research. Additionally, I enjoy communicating science to share insights and inspire curiosity, believing that research is most powerful when it’s accessible and widely understood.